COMMUNIQUÉS West-GlobeNewswire

Crinetics Pharmaceuticals Appoints Alan Krasner, M.D., as Chief Medical Officer

18/06/2018 - 22:05

SAN DIEGO, June 18, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine [...]

ContraVir Pharmaceuticals to Provide Corporate, Business and Clinical Updates

18/06/2018 - 22:01

Conference Call and Live Audio Webcast Scheduled for June 25, 2018, 4:30 p.m. ET EDISON, N.J., June 18, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the [...]

PSI Named Among Computerworld’s Best Places to Work in IT for Third Year in a Row

18/06/2018 - 20:55

ARLINGTON, Va., June 18, 2018 (GLOBE NEWSWIRE) -- Planned Systems International, Inc. (PSI), a leading provider of information technology (IT) solutions and services for the federal government, is pleased to announce [...]

INSYS Therapeutics Provides an Update on Its Ongoing Transformation

18/06/2018 - 18:58

PHOENIX, June 18, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today reiterated its [...]

Burcon Announces Fiscal 2018 Results and Reviews Operations

18/06/2018 - 18:57

VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX:BU), a leader in natural product extraction, purification and isolation technologies, reported results for the year [...]

CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social

18/06/2018 - 18:28

Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 18 juin 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]

CROSSJECT : Descriptif du programme de rachat d'actions 2018-2019

18/06/2018 - 18:20

Communiqué de Presse Descriptif du programme de rachat d'actions 2018-2019 Dijon, le 18 juin 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe et commercialisera prochainement un [...]

Sanofi: Disclosure of trading in own shares

18/06/2018 - 18:01

Attachment Disclosure of trading in own shares.pdf

Sanofi : Déclaration des transactions sur actions propres

18/06/2018 - 18:01

Pièce jointe Déclaration des transactions sur actions propres.pdf

Ossur Hf : Transactions in relation to share buyback program

18/06/2018 - 18:01

Announcement no. 40/2018 Reykjavik, 18 June 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]

TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of Ublituximab in Patients with Multiple Sclerosis at the 4th Congress of the European Academy of Neurology

18/06/2018 - 18:00

NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced updated results from the Phase 2 multicenter trial of ublituximab (TG-1101), the Company’s novel glycoengineered anti-CD20 [...]

GENFIT: OUTCOME OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 15, 2018

18/06/2018 - 17:49

GENFIT: OUTCOME OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 15, 2018 Lille (France), Cambridge (Massachusetts, United States), June 18, 2018 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), a [...]

GENFIT : RESULTATS DE L'ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 15 JUIN 2018

18/06/2018 - 17:49

GENFIT : RESULTATS DE L'ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 15 JUIN 2018 Lille (France), Cambridge (Massachusetts, Etats-Unis), le 18 juin 2018 - GENFIT (Euronext : GNFT - ISIN : FR0004163111), société [...]

IllumiCare integrates with Epic at multiple customers

18/06/2018 - 17:00

BIRMINGHAM, Ala., June 18, 2018 (GLOBE NEWSWIRE) -- IllumiCare, a pioneer in point-of-care healthcare information technology, announces today integrations with multiple health systems using the Epic electronic medical [...]

Dyadic International Improves Monoclonal Antibody (mAb) Productivity Utilizing C1 Gene Expression Platform to Manufacture Biologics

18/06/2018 - 15:50

Results Highlighted in BioProcess International and the Global Bioprocessing and Bioanalytics Congress 2018 JUPITER, Fla., June 18, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global [...]

PotNetwork Holdings, Inc. to File SEC Form 10 to Become Fully Reporting Company

18/06/2018 - 15:17

Company Prepares to Meet Uplisting Requirements to Achieve OTCQB Designation FT LAUDERDALE, Fla., June 18, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- PotNetwork Holdings, Inc. (OTC Pink:POTN) announced today that its [...]

OrthoPediatrics Corp. Announces First RESPONSE Spine Surgery Performed in Japan

18/06/2018 - 15:00

WARSAW, Ind., June 18, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the first [...]

Oncobiologics Announces Randy Thurman as Executive Chairman of the Board of Directors and Lawrence A. Kenyon as Interim CEO

18/06/2018 - 15:00

CRANBURY, N.J., June 18, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that Pankaj Mohan, Ph.D., its Chairman and Chief Executive Officer (CEO), has stepped down as CEO and Chairman of the [...]

Cannabix Technologies Provides Technology Update on Marijuana Breathalyzer Development

18/06/2018 - 14:45

The Cannabix Marijuana Breathalyzer is being developed to give law enforcement and employers a tool to enforce public safety VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE [...]